Fund managers

24Haymarket are a private capital firm focused on disruptive early stage venture and growth equity investments in the UK.  Since inception in 2012, we have invested more than £74 million in 50 companies holding an average of 18% equity ownership.

We follow a strict investment thesis with a focus on verticals – Digital Healthcare, Ed Tech, Cybersecurity, Enterprise Software, Supply Chain and Logistics Technology, Fin Tech, Insure Tech and Legal Services Tech – in the nascent stages of high growth where we can leverage proprietary insight from our Investor Network.  We adhere to an active investment philosophy with a right to a board seat in each investment we pursue combined with an involved post-investment model.

Headquartered in London, with a regional office in Edinburgh, we are distinguished by the calibre and engagement of the 24Haymarket Investor Network.  Our Investor Network includes 100+ senior business leaders combining 3,000+ years of business experience with Director-level experience in companies worth a collective £700 billion.

Committed Capital Ltd is an investment and corporate advisory business founded in 2001 on the basis that investee companies need support as well as cash to realise their plans.

The team has a proven track record of working with UK based, post revenue, growth stage technology companies to create value for shareholders through careful investment selection, rigorous investment due diligence, efficient transaction execution and providing investee companies with ongoing hands-on support.

The Committed Capital Growth EIS Fund is an evergreen fund providing investors with a diversified portfolio of 8-12 EIS qualifying investee companies, with a target return in line with our track record of 2-3 x ROI (excluding tax relief).

Praetura Investments is an FCA Authorised Firm having completed its first Venture Capital transaction in 2011, the acquisition and listing of Inspired Energy plc in November of that year. Since, we have grown steadily and have made a further 24 investments on behalf of investors having invested over £100m into high growth tech or IP enabled small businesses.

We’ve built a highly experienced and reputable team within Praetura Investments who bring with them over 250 year of sector experience having raised and transacted over £8bn within the UK.

Headquartered in the North West, the Praetura team have built an enviable network across the region generating strong deal flow and opportunities. The investment strategy has been developed and refined over the previous 8 years and we’ve built a reputation for being able to identify and back high performing, entrepreneurial teams who demonstrate they can execute their plan. As important is our ability to add “more than money”. We look for ways we can add significant value through our team’s skillset, network and experience. Deciding whether we can add value and help shape a company’s growth is critical when we decide where to invest.

The SidebySide EIS Venture Fund invests in fast-growing technology-enabled businesses with £1-10 million in revenue. These more established companies will usually be at least several years old and typically have over 30 employees. We look for companies where there is evidence of a strong customer acceptance of the product and service offered, and where we believe we can add substantively to the knowledge and experience of the management team as the company grows.

o2h Ventures, a specialist biotech fund manager based in the heart of the thriving biotech community in Cambridge, UK. We invest in early-stage biotech companies involved in novel drug discovery, enabling service tools, and AI/ML technologies. Currently, we have two tax-efficient human health funds open for investment: the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme.

To date, through our funds, we have invested over $10 million in 35+ early-stage biotech companies, empowering impactful research addressing unmet medical needs in areas such as cancer, depression, diseases of the ear and eye, psoriasis, idiopathic pulmonary fibrosis, anti-ageing, and infectious diseases. For more details, please see – www.o2hventures.com